Showing results (111-120 of 206) with videos related to
Sort By:
Pageof 21
Journal of Autoimmunity|December 8, 2023
Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) ProgramEmily C Somers, Jaclyn M Goodrich, Lu Wang, et al.Lupus Science & Medicine|December 5, 2019
Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance ProgramPeter Izmirly, Jill Buyon, H Michael Belmont, et al.Rheumatology (Oxford, England)|April 2, 2013
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-upDaniel J Wallace, Caroline Gordon, Vibeke Strand, et al.Arthritis and Rheumatism|December 30, 2009
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trialJoan T Merrill, C Michael Neuwelt, Daniel J Wallace, et al.Eclinicalmedicine|October 21, 2024
Neuropsychiatric prodromes and symptom timings in relation to disease onset and/or flares in SLE: results from the mixed methods international INSPIRE studyMelanie Sloan, James A Bourgeois, Guy Leschziner, et al.Arthritis and Rheumatism|December 1, 2007
British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosusChee-Seng Yee, Vernon Farewell, David A Isenberg, et al.Rheumatology (Oxford, England)|February 26, 2010
Numerical scoring for the BILAG-2004 indexChee-Seng Yee, Lynne Cresswell, Vernon Farewell, et al.MMWR. Morbidity and Mortality Weekly Report|September 27, 2019
Prescription Opioid Use in Patients With and Without Systemic Lupus Erythematosus - Michigan Lupus Epidemiology and Surveillance Program, 2014-2015Emily C Somers, Jiha Lee, Afton L Hassett, et al.Rheumatology (Oxford, England)|January 20, 2011
The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patientsChee-Seng Yee, Vernon T Farewell, David A Isenberg, et al.Rheumatology (Oxford, England)|August 22, 2012
The BILAG-2004 systems tally--a novel way of representing the BILAG-2004 index scores longitudinallyChee-Seng Yee, Caroline Gordon, David A Isenberg, et al.Pageof 21